D-Amphetamine Sulfate

Category
CNS, ADHD
Product code
51-63-8

D-Amphetamine Sulfate is a central nervous system (CNS) stimulant active pharmaceutical ingredient widely used in the treatment of attention-deficit hyperactivity disorder (ADHD) and narcolepsy. By increasing the release of norepinephrine and dopamine in the brain, D-Amphetamine Sulfate enhances focus, attention, and wakefulness while reducing impulsivity and hyperactivity. Pharmaceutical companies formulate D-Amphetamine Sulfate into oral tablets and extended-release capsules, providing flexible dosing options to support sustained therapeutic effects throughout the day.

Common D-Amphetamine Sulfate Uses and Treated Conditions

  • Attention-Deficit Hyperactivity Disorder (ADHD) – Improves attention span, focus, and impulse control in children and adults.
  • Narcolepsy – Promotes wakefulness and reduces excessive daytime sleepiness.
  • Cognitive Enhancement in Specific Clinical Contexts – Supports improved mental alertness under medical supervision.
  • Off-Label Therapeutic Uses – Occasionally applied in conditions requiring CNS stimulation under strict regulatory guidance.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures D-Amphetamine Sulfate API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on D-Amphetamine Sulfate, visit the official CAS webpage.

If you’d like more information or to request a sample, contact our Generic API team today.

D-Amphetamine Sulfate

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us